{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:17:15Z","timestamp":1788985035664,"version":"build-2803163510"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,13]]},"DOI":"10.1093\/cid\/cix666","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T07:08:58Z","timestamp":1503385738000},"page":"1897-1904","source":"Crossref","is-referenced-by-count":53,"title":["Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy"],"prefix":"10.1093","volume":"65","author":[{"given":"Shabir A","family":"Madhi","sequence":"first","affiliation":[{"name":"Medical Research Council: Respiratory and Meningeal Pathogens Research Unit"},{"name":"Department of Science and Technology\/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand"},{"name":"National Institute for Communicable Diseases, National Health Laboratory Service, Centre for Vaccines and Immunology, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthonet","family":"Koen","sequence":"additional","affiliation":[{"name":"Medical Research Council: Respiratory and Meningeal Pathogens Research Unit"},{"name":"Department of Science and Technology\/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare L","family":"Cutland","sequence":"additional","affiliation":[{"name":"Medical Research Council: Respiratory and Meningeal Pathogens Research Unit"},{"name":"Department of Science and Technology\/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Jose","sequence":"additional","affiliation":[{"name":"Medical Research Council: Respiratory and Meningeal Pathogens Research Unit"},{"name":"Department of Science and Technology\/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niresha","family":"Govender","sequence":"additional","affiliation":[{"name":"Medical Research Council: Respiratory and Meningeal Pathogens Research Unit"},{"name":"Department of Science and Technology\/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Wittke","sequence":"additional","affiliation":[{"name":"GSK and Novartis Vaccines Division, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morounfolu","family":"Olugbosi","sequence":"additional","affiliation":[{"name":"GSK and Novartis Vaccines Division, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajoke","family":"Sobanjo-ter Meulen","sequence":"additional","affiliation":[{"name":"GSK and Novartis Vaccines Division, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherryl","family":"Baker","sequence":"additional","affiliation":[{"name":"GSK and Novartis Vaccines Division, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M","family":"Dull","sequence":"additional","affiliation":[{"name":"GSK and Novartis Vaccines Division, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vas","family":"Narasimhan","sequence":"additional","affiliation":[{"name":"GSK and Novartis Vaccines Division, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Slobod","sequence":"additional","affiliation":[{"name":"GSK and Novartis Vaccines Division, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,23]]},"reference":[{"key":"key\n\t\t\t\t20180306232501_CIT0001","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(11)61651-6","article-title":"Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis","volume":"379","author":"Edmond","year":"2012","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306232501_CIT0002","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1001\/jama.299.17.2056","article-title":"Epidemiology of invasive group B streptococcal disease in the United States, 1999\u20132005","volume":"299","author":"Phares","year":"2008","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180306232501_CIT0003","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12887-015-0460-2","article-title":"Incidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country observational study","volume":"15","author":"Rivera","year":"2015","journal-title":"BMC Pediatr"},{"key":"key\n\t\t\t\t20180306232501_CIT0004","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/INF.0000000000001233","article-title":"Disease burden of group B Streptococcus among infants in sub-Saharan Africa: a systematic literature review and meta-analysis","volume":"35","author":"Sinha","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180306232501_CIT0005","doi-asserted-by":"crossref","first-page":"e0169101","DOI":"10.1371\/journal.pone.0169101","article-title":"Temporal changes in invasive group B Streptococcus serotypes: implications for vaccine development","volume":"11","author":"Dangor","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180306232501_CIT0006","doi-asserted-by":"crossref","first-page":"D3","DOI":"10.1016\/j.vaccine.2013.02.030","article-title":"The spectrum of perinatal group B streptococcal disease","volume":"31","author":"Baker","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306232501_CIT0007","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.clp.2010.02.002","article-title":"Group B streptococcal disease in infants: progress in prevention and continued challenges","volume":"37","author":"Verani","year":"2010","journal-title":"Clin Perinatol"},{"key":"key\n\t\t\t\t20180306232501_CIT0008","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1542\/peds.2012-1231","article-title":"Group B Streptococcus late-onset disease: 2003\u20132010","volume":"131","author":"Berardi","year":"2013","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20180306232501_CIT0009","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/infdis\/jit549","article-title":"Maternal antibody at delivery protects neonates from early onset group B streptococcal disease","volume":"209","author":"Baker","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306232501_CIT0010","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1086\/323350","article-title":"Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study","volume":"184","author":"Lin","year":"2001","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306232501_CIT0011","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1086\/422756","article-title":"Level of maternal IgG anti-group B Streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen","volume":"190","author":"Lin","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306232501_CIT0012","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.vaccine.2015.12.072","article-title":"Status of vaccine research and development of vaccines for GBS","volume":"34","author":"Heath","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306232501_CIT0013","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fimmu.2014.00446","article-title":"Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies","volume":"5","author":"Niewiesk","year":"2014","journal-title":"Front Immunol"},{"key":"key\n\t\t\t\t20180306232501_CIT0014","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/cid\/civ695","article-title":"Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator","volume":"61","author":"Ladhani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306232501_CIT0015","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.vaccine.2016.02.044","article-title":"A randomized, observer-blind phase Ib study to identify formulations and vaccine schedules of a trivalent group B Streptococcus vaccine for use in non-pregnant and pregnant women","volume":"34","author":"Leroux-Roels","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306232501_CIT0016","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1473-3099(16)00152-3","article-title":"Safety and immunogenicity of an investigational maternal trivalent group B Streptococcus vaccine in healthy women and their infants: a randomised phase 1b\/2 trial","volume":"16","author":"Madhi","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180306232501_CIT0017","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/AOG.0000000000001190","article-title":"Maternal immunization with an investigational trivalent group B streptococcal vaccine: a randomized controlled trial","volume":"127","author":"Donders","year":"2016","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20180306232501_CIT0018","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1086\/516154","article-title":"Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine","volume":"25","author":"Pichichero","year":"1997","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306232501_CIT0019","doi-asserted-by":"crossref","first-page":"e74906","DOI":"10.1371\/journal.pone.0074906","article-title":"Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes","volume":"8","author":"Grant","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180306232501_CIT0020","first-page":"24","article-title":"Diphtheria vaccine\u2014WHO position paper","volume":"81","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180306232501_CIT0021","first-page":"129","article-title":"Pneumococcal vaccines WHO position paper\u20142012","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180306232501_CIT0022","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/INF.0000000000001345","article-title":"Epidemiology of late and very late onset group B streptococcal disease: fifteen-year experience from two Australian tertiary pediatric facilities","volume":"36","author":"Bartlett","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180306232501_CIT0023","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/INF.0000000000001414","article-title":"Neonatal group B streptococcus infections: prevention strategies, clinical and microbiologic characteristics in 7 years of surveillance","volume":"36","author":"Creti","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180306232501_CIT0024","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/INF.0000000000000640","article-title":"Relevance of age at diagnosis to prevention of late-onset group B streptococcal disease by maternal immunization","volume":"34","author":"Edwards","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180306232501_CIT0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1179\/000349803125002814","article-title":"High burden of invasive Streptococcus agalactiae disease in South African infants","volume":"23","author":"Madhi","year":"2003","journal-title":"Ann Trop Paediatr"},{"key":"key\n\t\t\t\t20180306232501_CIT0026","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/jpids\/piv067","article-title":"Risk factors for late-onset group B streptococcal disease before and after implementation of universal screening and intrapartum antibiotic prophylaxis","volume":"5","author":"Pintye","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key\n\t\t\t\t20180306232501_CIT0027","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cmi.2015.05.039","article-title":"Group B Streptococcus neonatal invasive infections, France 2007\u20132012","volume":"21","author":"Joubrel","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180306232501_CIT0028","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/S0264-410X(03)00353-0","article-title":"Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine","volume":"21","author":"Baker","year":"2003","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306232501_CIT0029","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/QCO.0000000000000266","article-title":"Group B Streptococcus: developing a correlate of protection for a vaccine against neonatal infections","volume":"29","author":"Dangor","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20180306232501_CIT0030","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1016\/j.vaccine.2015.10.019","article-title":"Correlates of protection of serotype-specific capsular antibody and invasive group B Streptococcus disease in South African infants","volume":"33","author":"Dangor","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306232501_CIT0031","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1016\/j.vaccine.2014.08.038","article-title":"The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels\u2014a prospective study","volume":"32","author":"Abu Raya","year":"2014","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306232501_CIT0032","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1016\/j.vaccine.2016.05.051","article-title":"Pertussis vaccination during pregnancy: antibody persistence in infants","volume":"34","author":"Vilajeliu","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306232501_CIT0033","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.vaccine.2013.01.011","article-title":"Kinetics of maternally acquired anti-hepatitis A antibodies: prediction of waning based on maternal or cord blood antibody levels","volume":"31","author":"Brinkhof","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306232501_CIT0034","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/infdis\/jiv339","article-title":"Kinetics of hemagglutination-inhibiting antibodies following maternal influenza vaccination among mothers with and those without HIV infection and their infants","volume":"212","author":"Nunes","year":"2015","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306232501_CIT0035","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/infdis\/jiu316","article-title":"Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh","volume":"210","author":"Chu","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306232501_CIT0036","first-page":"243","article-title":"Pharmacokinetics of intravenous immunoglobulin in neonates","volume":"57","author":"Weisman","year":"1989","journal-title":"Vox Sang"},{"key":"key\n\t\t\t\t20180306232501_CIT0037","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/21645515.2015.1127485","article-title":"Vaccines in pregnancy: the dual benefit for pregnant women and infants","volume":"12","author":"Marshall","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20180306232501_CIT0038","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306232501_CIT0039","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1016\/j.vaccine.2010.09.047","article-title":"Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccines","volume":"28","author":"Wysocki","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306232501_CIT0040","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1128\/IAI.70.4.1724-1738.2002","article-title":"Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14","volume":"70","author":"Guttormsen","year":"2002","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180306232501_CIT0041","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2011.04.068","article-title":"Mother-infant vaccination with pneumococcal polysaccharide vaccine: persistence of maternal antibodies and responses of infants to vaccination","volume":"29","author":"Holmlund","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306232501_CIT0042","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1016\/j.vaccine.2013.08.009","article-title":"Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule","volume":"31","author":"Rodgers","year":"2013","journal-title":"Vaccine"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/65\/11\/1897\/24266917\/cix666.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T23:25:18Z","timestamp":1520378718000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/65\/11\/1897\/4209620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,23]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,9,23]]},"published-print":{"date-parts":[[2017,11,13]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix666","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12,1]]},"published":{"date-parts":[[2017,9,23]]}}}